Your browser doesn't support javascript.
loading
Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
Indian J Ophthalmol ; 1997 Sep; 45(3): 177-80
Article in English | IMSEAR | ID: sea-70483
ABSTRACT
The efficacy of topical ketorolac 0.5% in treatment of vernal keratoconjunctivitis (VKC) was evaluated in a randomised double-blind prospective trial in 21 patients. Ketorolac treated eyes showed 50.7% reduction in main symptoms of itching compared to 33.3% relief in placebo treated eyes after 2 weeks of treatment (p < 0.01). Photophobia, ropy discharge, and conjunctival injection also lessened by 39.9%, 31.6%, and 39.1%, respectively, in ketorolac treated eyes compared to 23.8%, 17.3%, and 20.3% in placebo group. Transient stinging sensation was observed in 3 (14.3%) patients on ketorolac therapy. This study shows efficacy of ketorolac 0.5% solution in controlling symptoms in VKC.
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Ophthalmic Solutions / Safety / Conjunctivitis, Allergic / Female / Humans / Male / Child / Child, Preschool / Tolmetin / Anti-Inflammatory Agents, Non-Steroidal Type of study: Controlled clinical trial / Observational study Language: English Journal: Indian J Ophthalmol Year: 1997 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Ophthalmic Solutions / Safety / Conjunctivitis, Allergic / Female / Humans / Male / Child / Child, Preschool / Tolmetin / Anti-Inflammatory Agents, Non-Steroidal Type of study: Controlled clinical trial / Observational study Language: English Journal: Indian J Ophthalmol Year: 1997 Type: Article